CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

LONALeonaBio, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $3.57 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$33.64M
CountryUSA
RECENT INSIDER TRADES
  • 2026-03-05 · Renninger Robert (CHIEF FINANCIAL OFFICER) · SELL
  • 2026-03-05 · CHURCH KEVIN (CHIEF SCIENTIFIC OFFICER) · SELL
  • 2026-03-05 · Litton Mark James (PRESIDENT and CEO) · SELL
  • 2026-03-05 · San Martin Javier (CHIEF MEDICAL OFFICER) · SELL
  • 2026-03-05 · Worthington Mark (GENERAL COUNSEL and CCO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders46
Shares held7,425,472
Value$67.90M
Percent of shares outstanding78.81%
As of quarter end2026-06-30
RECENT NEWS
  • LONA halted · Volatility pause (LULD)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
LeonaBio, Inc. (LONA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit